Failing to contain ‘superbugs’ across nursing homes can have serious consequences, with the elderly highly vulnerable to deadly illness. A new national trial aiming to address this major health problem has received $2.3 million in Federal and University funding.
Researchers from Monash University, Alfred Health, Bio21 and the University of Sydney, led by Professor Anton Peleg, of the Monash Biomedicine Discovery Institute and Central Clinical School, have received $2.3 million in federal and University funding to start a national trial involving residential aged care facilities. This trial aims to determine the amount of antibiotic-resistant bacteria within these facilities, and how best practice antibiotic use can control the rise of these ‘superbugs’.
Read the full story on the Monash Biomedicine Discovery Institute website f